Skip to main content
Toggle navigation
Login
Search
Home
Tweets by 2023 SSO Annual Meeting
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Home
Browse by Speaker
Browse by Speaker
Browse by Speaker
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
K
Kümmel, Sherko
Breast Unit, Clinic Essen-Mitte, Essen, Germany; Department of Gynecology and Breast Center, Charité University Hospital, Berlin, Germany
17: Axillary dissection to determine nodal burden to inform systemic therapy recommendations for clinically node-positive breast cancer: Pre-planned substudy of TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)
Location:Veterans Memorial Auditorium
Sherko Kümmel
Kadera, Brian
University of California, Los Angeles
79: Dysregulation of Mitochondrial Dynamics via Dynamin-Related Protein 1 Implicated in Dedifferentiated Liposarcoma
Location:Ballroom A
Brian Kadera
The Current Management of Desmoids: So Much More Than Surgery
Location:SSO HUB: Rare/Metastatic Cancers Zone
Brian Kadera
Kadiyala, Padma
University of Michigan
41: Defining the immune microenvironment surrounding pancreatic cancer using single cell RNA sequencing
Location:Ballroom B
Padma Kadiyala
Kaitlyn, Kelly
Department of Surgery, University of Wisconsin
43: Optimal Duration of Chemotherapy in the Era of Neoadjuvant Therapy for Pancreatic Adenocarcinoma - Is There a Magic Number?
Location:Ballroom B
Kelly Kaitlyn
Kajihara, Ryutaro
Kumamoto University - Department of Biomedical Labarotory Sciences
94: Single-cell profiling of tumor-infiltrating T-cell clones in longitudinal peripheral blood samples for clinical studies
Location:Ballroom A
Ryutaro Kajihara
Kakish, Hanna
University Hospitals, Cleveland Medical Center
31: Factors Predicting Immunotherapy Utilization for Metastatic Merkel Cell Carcinoma from 2015-2018
Location:Ballroom A
Hanna Kakish
P69: Understanding Factors Leading to Surgical Attrition for “Resectable” Gastric Cancer
Location:SSO HUB: Rare/Metastatic Cancers Zone
Hanna Kakish
Kaklamani, Virginia
University of Texas Health Sciences Center
P7: Genomic characterization of breast cancer metastases reveals differences in rates of PIK3CA mutation across metastatic sites and worse survival in patients with concurrent CDH1 mutation treated with PI3K inhibitor
Location:SSO HUB: Breast & Endocrine Zone
Virginia Kaklamani
Kalady, Matthew
The Ohio State University and James Comprehensive Cancer Center
26: Neoadjuvant Chemoradiation Does Not Improve Outcomes for Patients Undergoing Resection for Upper Rectal Cancer: A US Rectal Cancer Consortium Analysis
Location:Ballroom C
Matthew Kalady
Implementing a Watch and Wait Program
Location:Ballroom B
Matthew Kalady
P13: Multiomic Profile of Colorectal Cancer Cell Line Radiosensitivity
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Matthew Kalady
Questions and Discussions
Location:Ballroom B
Matthew Kalady
Kale, Sachin
The Ohio State University Wexner Medical Center
P76: Surgeon Perspectives on Management of Aborted Cancer Surgery: Results of an SSO Member Survey
Location:SSO HUB: Rare/Metastatic Cancers Zone
Sachin Kale
Kaliwal, Yosuf
ICES
84: The association between familiarity of the surgeon-anesthesiologist dyad and post-operative patient outcomes for complex gastrointestinal cancer surgery: a population-based study.
Location:Ballroom B
Yosuf Kaliwal
Kalvin, Hannah
Memorial Sloan Kettering Cancer Center
27: The Prognostic Value of Pre- and Post-Neoadjuvant Chemotherapy Serum Carcinoembryonic Antigen Levels in Patients Having Resection of Colorectal Liver Metastases
Location:Ballroom C
Hannah Kalvin
P73: How much does postoperative pain interfere with activities of daily living after breast surgery?
Location:SSO HUB: Rare/Metastatic Cancers Zone
Hannah Kalvin
Kamgar, Mandana
Medical College of Wisconsin
48: Machine Learning Derived Electronic Tumor Marker Mimics Prognostic Properties of CA19-9
Location:Ballroom A
Mandana Kamgar
Kandil, Emad
Tulane University
RFA of Thyroid Nodules is this for Real?
Location:SSO HUB: Breast & Endocrine Zone
Emad Kandil
Kane, John
Rowell Park Comprehensive Cancer Center
Endocrine/H & N and Sarcoma Parallel Session
Location:Ballroom A
John Kane
Kantor, Olga
Brigham and Women's Hospital
2: Racial disparities in locoregional recurrence in patients with stage I-III, hormone receptor positive breast cancer enrolled in the NSABP B-42 trial
Location:Veterans Memorial Auditorium
Olga Kantor
Kanu, Elishama
Duke University Medical Center
P33: Personalized Circulating Tumor DNA and Survival in Patients with Resectable Pancreatic Cancer
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Elishama Kanu
P60: Evolution in management of upfront treatment for desmoid tumors
Location:SSO HUB: Melanoma & Sarcoma Zone
Elishama Kanu
P79: Impact of Tumor Size and Management on Survival in Gastric GIST
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Elishama Kanu
Kaoutzanis, Christodoulos
University of Colorado School of Medicine, Department of Surgery
P9: Comparing Patient Reported Outcomes for Same-day Discharge and Inpatient Admission After Mastectomy
Location:SSO HUB: Breast & Endocrine Zone
Christodoulos Kaoutzanis
Karakousis, Giorgos
Hospital of the University of Pennsylvania
56: International Validation Study of the Melanoma Institute Australia Sentinel Node Metastasis Risk Nomogram
Location:Veterans Memorial Auditorium
Giorgos Karakousis
58: Timing of Adjuvant Immunotherapy in Stage III Melanoma, Does it Matter?
Location:Veterans Memorial Auditorium
Giorgos Karakousis
72: Cost Analysis and Financial Implications of Cytoreductive Surgery and HIPEC: a US Single Center Experience
Location:Ballroom B
Giorgos Karakousis
Regional Therapies for Soft Tissue Sarcomas
Location:SSO HUB: Melanoma & Sarcoma Zone
Giorgos Karakousis
P18: Perioperative Outcomes of Robotic and Laparoscopic Surgery for Colorectal Cancer: A Propensity Score Matched Analysis
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Giorgos Karakousis
Sarcoma Poster Presentations 2
Location:SSO HUB: Melanoma & Sarcoma Zone
Giorgos Karakousis
Karalis, John
University of Texas Southwestern Medical Center
96: Serum IL-6 level predicts survival and treatment response in gastric and gastroesophageal junction cancer
Location:Ballroom A
John Karalis
Karlan, Scott
Cedars-Sinai Medical Center
15: A Prospective Study of Sentinel Node Biopsy Omission in Women Age ≥ 65 with Early Invasive ER+ Breast Cancer Undergoing Breast Conserving Surgery
Location:Veterans Memorial Auditorium
Scott Karlan
Karnezis, Anthony
Department of Pathology and Laboratory Medicine, UC Davis
P37: Characterization of Natural Killer and Cytotoxic T Cell Immune Infiltrates in Pancreatic Ductal Adenocarcinoma
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Anthony Karnezis
Kashani-Sabet, Mohammed
California Pacific Medical Center, San Francisco, CA
56: International Validation Study of the Melanoma Institute Australia Sentinel Node Metastasis Risk Nomogram
Location:Veterans Memorial Auditorium
Mohammed Kashani-Sabet
Kasumova, Gyulnara
Ohio State University/ James Cancer Hospital
67: Molecular mechanism of colorectal peritoneal metastasis: an interesting TWIST
Location:Ballroom B
Gyulnara Kasumova
Katz, Matthew
The University of Texas MD Anderson Cancer Center
Getting Involved in the Cooperative Groups: Where Do I Start?
Location:Room 302
Matthew Katz
How to Design a Successful Trial
Location:SSO HUB Theater
Matthew Katz
P39: Effect of Surgical Approach on Early Return to Intended Oncologic Therapy After Resection for Pancreatic Ductal Adenocarcinoma
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Matthew Katz
P75: “Next Gen” Operative Notes – synoptic operative reporting for cancer surgery
Location:SSO HUB: Rare/Metastatic Cancers Zone
Matthew Katz
Kaufman, Howard
Massachusetts General Hospital
The Evolution of Novel Combination Immunotherapies – Intralesional Treatments and New Targets for Treatment
Location:SSO HUB: Immuno-Oncology Zone
Howard Kaufman
Kaul, Vivek
University of Rochester Medical Center
P34: Determining Safety and Tolerability of SX-682 in Combination with Anti-PD1 as Maintenance Therapy for Unresectable Pancreatic Adenocarcinoma, A Phase I Study
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Vivek Kaul
Kawazu, Masahito
Division of Cell Therapy, Chiba Cancer Center
P24: Genome doubling shapes the evolution and prognosis of advanced head and neck cancer
Location:SSO HUB: Breast & Endocrine Zone
Masahito Kawazu
Kelly, Ciara
Department of Medicine
74: Interim Results of a Phase II Trial of Regional Melphalan via Limb Infusion and Systemic PD1 Blockade in Patients with Extremity Sarcoma
Location:Veterans Memorial Auditorium
Ciara Kelly
Kelly, Kaitlyn
Meet the Experts: Current Controversies in the Management of Gastric Cancer
Location:Room 304
Kaitlyn Kelly
P83: Primary and Metastatic Gastric Cancers in Patient-derived Orthotopic Xenografts Brightly Labeled by Fluorescent anti-CEA Antibody
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Kaitlyn Kelly
Kelly, Yvonne
Columbia University
P56: A Data Driven Approach for Individualized Risk Prediction of Serious Complications After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
Location:SSO HUB: Rare/Metastatic Cancers Zone
Yvonne Kelly
Kemeny, Nancy
Memorial Sloan Kettering Cancer Center
35: Genetic Heterogeneity of Intrahepatic Cholangiocarcinoma: Implications for Outcome
Location:Veterans Memorial Auditorium
Nancy Kemeny
37: Hepatic Artery Infusion Chemotherapy Compared to Y90 for Treatment of Unresectable Colorectal Liver Metastases: A Multi-Institutional Comparative Study
Location:Ballroom B
Nancy Kemeny
52: Adjuvant chemotherapy for resected intrahepatic cholangiocarcinoma confers no survival advantage.
Location:Ballroom A
Nancy Kemeny
Kendra, Kari
Ohio State University James Cancer Hospital, Columbus, OH, USA
57: Neoadjuvant Pembrolizumab in Stage II-III Desmoplastic Melanoma (SWOG S1512): Surgical Considerations
Location:Veterans Memorial Auditorium
Kari Kendra
Kendrick, Michael
Division of Hepatobiliary and Pancreas Surgery, Mayo Clinic
51: Response to neoadjuvant chemotherapy in invasive intraductal papillary mucinous cystic neoplasm compared to de novo pancreatic ductal adenocarcinoma
Location:Ballroom A
Michael Kendrick
70: Oncologic outcomes of cytoreductive surgery and HIPEC for highly selected patients with pancreatic ductal adenocarcinoma
Location:Ballroom B
Michael Kendrick
P31: Accuracy of DOTATATE PET/CT in the Preoperative Planning of Small Bowel Neuroendocrine Tumor Resection
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Michael Kendrick
P84: Outcomes After Minimally Invasive Gastrectomy for Locally Advanced Gastric Cancer
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Michael Kendrick
Kennedy, Emma
University of Pennsylvania, Medical Genetics
P25: What are the clinical implications of SDHA pathogenic variants?
Location:SSO HUB: Breast & Endocrine Zone
Emma Kennedy
Khajoueinejad, Nazanin
Icahn School of Medicine at Mount Sinai
P80: Accuracy of Clinical Staging for Intramural (T2) Gastric Cancer: Survival Outcomes Following Upfront Surgical Resection Compared to Risk of Overtreatment with Neoadjuvant Therapy
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Nazanin Khajoueinejad
Khan, Asama
Department of Surgery, Memorial Sloan Kettering Cancer Center
P20: Microsatellite Instability (MSI): The Transition from Favorable to Unfavorable Outcomes with Lymph Node Metastases
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Asama Khan
Khan, Hamza
Valley Health System
28: Tumor Deposits Are Associated with a Higher Risk of Peritoneal Disease in Non-Metastatic Colorectal Cancer Patients
Location:Ballroom C
Hamza Khan
Khan, Jamal
Virginia Commonwealth University School of Medicine
13: Luminal A vs B After Choosing Wisely: Do Phenotypes Affect Oncologic Outcomes?
Location:Veterans Memorial Auditorium
Jamal Khan
Khan, Sajid
Yale University
20: Multi-omic Analysis Reveals Potential Mechanisms of EGFR-inhibitor Resistance in Right Sided Colon Cancer Liver Metastases
Location:Veterans Memorial Auditorium
Sajid Khan
Khan, Tahsin
National Cancer Institute
40: Pre-clinical and clinical evaluation of tivozanib for Exportin 7/Ste20-like-kinase (XPO7/SLK)-expressing cholangiocarcinoma
Location:Ballroom B
Tahsin Khan
Khattak, Muhammad
Fiona Stanley Hospital and Edith Cowan University, Perth, WA, Australia
54: Adjuvant Pembrolizumab in Stage II Melanoma: Outcomes by Tumor Location in the Phase 3 KEYNOTE-716 Study
Location:Veterans Memorial Auditorium
Muhammad Khattak
Khokar, Amna
John H. Stroger Jr. Cook County Hospital
33: Validated Predictive Model for Prognosis and Treatment of Papillary Thyroid Carcinoma
Location:Ballroom A
Amna Khokar
Khomiak, Andrii
University of Colorado School of Medicine, Department of Surgery
P19: Pathological Features Associated With Lymph Node Disease in Patients with Appendiceal Neuroendocrine Tumors.
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Andrii Khomiak
Khushalani, Nikhil
H. Lee Moffitt Cancer Center, Tampa, FL, USA
64: Lifileucel TIL Cell Therapy in Patients With Advanced Melanoma After Progression on Immune Checkpoint Inhibitors (ICI) and Targeted Therapy: Tumor Tissue Procurement Data from the C-144-01 Study
Location:Veterans Memorial Auditorium
Nikhil Khushalani
Kidane, biniam
University of Manitoba
84: The association between familiarity of the surgeon-anesthesiologist dyad and post-operative patient outcomes for complex gastrointestinal cancer surgery: a population-based study.
Location:Ballroom B
biniam Kidane
Kiernan, Colleen
Vanderbilt University Medical Center
P21: Utility of near infrared autofluorescence detection of small bowel neuroendocrine tumors to guide extent of resection
Location:SSO HUB: Breast & Endocrine Zone
Colleen Kiernan
P22: Adoption of Robotic Adrenalectomy is Associated with a Short Learning Curve and Improved Outcomes
Location:SSO HUB: Breast & Endocrine Zone
Colleen Kiernan
Re-operative and Nonlocalized Parathyroid Cases
Location:SSO HUB: Breast & Endocrine Zone
Colleen Kiernan
Kim, Alex
The Ohio State University Wexner Medical Center, The James Cancer Hospital and Solove Research Institute
34: An Artificial Intelligence Approach to Determining Optimal Margin Width in Patients Undergoing Hepatectomy for Intrahepatic Cholangiocarcinoma
Location:Veterans Memorial Auditorium
Alex Kim
65: Detection of Residual Peritoneal Metastases Following Cytoreductive Surgery Using Pegsitacianine, a pH Sensitive Imaging Agent: Topline Results from a Phase 2 Study
Location:Veterans Memorial Auditorium
Alex Kim
67: Molecular mechanism of colorectal peritoneal metastasis: an interesting TWIST
Location:Ballroom B
Alex Kim
80: Disparities in Socioeconomic Mediation of Racial Segregation in Hepatopancreaticobiliary Cancer
Location:Veterans Memorial Auditorium
Alex Kim
82: Socioeconomic Disparities in the Treatment and Survival of Extremity Soft Tissue Sarcoma
Location:Ballroom B
Alex Kim
P57: Phosphorylation of IWS1 by AKT Maintains Liposarcoma Tumor Heterogeneity through Preservation of Cancer Stem Cell Phenotypes and Mesenchymal-Epithelial Plasticity
Location:SSO HUB: Melanoma & Sarcoma Zone
Alex Kim
P59: Comparing complete compartmental resection with tumor only resection of retroperitoneal soft tissue sarcoma using the win ratio
Location:SSO HUB: Melanoma & Sarcoma Zone
Alex Kim
P65: A National Assessment of Differences in Gastric Cancer Outcomes Among Asian Ethnic Subgroups
Location:SSO HUB: Rare/Metastatic Cancers Zone
Alex Kim
Kim, Alexia
Stanford University
39: Mechanoresponsive Pancreatic Ductal Adenocarcinoma Cancer Associated Fibroblasts Shows an FAK-Dependent Subtype Divergent from Canonical Fibrotic TGFB-Pathway Dependence
Location:Ballroom B
Alexia Kim
Kim, Charles
Duke University Medical Center
P60: Evolution in management of upfront treatment for desmoid tumors
Location:SSO HUB: Melanoma & Sarcoma Zone
Charles Kim
Kim, Hong Jin
University of North Carolina at Chapel Hill
43: Optimal Duration of Chemotherapy in the Era of Neoadjuvant Therapy for Pancreatic Adenocarcinoma - Is There a Magic Number?
Location:Ballroom B
Hong Jin Kim
Kim, Hyoung-II
Yonsei University
Short- and Long-Term Outcomes
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Hyoung-II Kim
Kim, Jae
CITY OF HOPE CANCER CENTER
P78: Pilot Study of a Telehealth Intervention for Self-Management of Eating after Gastroesophageal Cancer Surgery
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Jae Kim
Kim, Jeesun
Seoul National University Hospital
92: Long-term outcomes of proximal gastrectomy for upper third advanced gastric and Siewert type II esophagogastric junction cancers in comparison with total gastrectomy: a propensity-score matched analysis
Location:Ballroom A
Jeesun Kim
Kim, Jin
Memorial Sloan Kettering Cancer Center
21: Organ Preservation, Compliance and Toxicity in Rectal Cancer Patients Treated with Total Neoadjuvant Therapy: A Post Hoc Analysis of the of the OPRA Phase II Trial
Location:Ballroom C
Jin Kim
Kim, Joseph
Department of Surgery, The University of Kentucky College of Medicine
P40: Exosomal isolation of immune checkpoints from pancreatic ductal adenocarcinoma patient-derived organoids
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Joseph Kim
Kim, Lawrence
University of North Carolina at Chapel Hill
29: Development of a novel PET agent for parathyroid imaging targeting the Calcium-Sensing Receptor (CaSR)
Location:Ballroom A
Lawrence Kim
Kim, Michael
MD Anderson Cancer Center
P39: Effect of Surgical Approach on Early Return to Intended Oncologic Therapy After Resection for Pancreatic Ductal Adenocarcinoma
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Michael Kim
Kim, Minji
Memorial Sloan Kettering
19: Sexual Well-being in Patients with Breast Cancer Surgery: Trends, Associated Factors, and Interventions.
Location:Veterans Memorial Auditorium
Minji Kim
Kim, Simon
University of Colorado School of Medicine, Department of Surgery
P9: Comparing Patient Reported Outcomes for Same-day Discharge and Inpatient Admission After Mastectomy
Location:SSO HUB: Breast & Endocrine Zone
Simon Kim
Kim, Teresa
University of Washington School of Medicine
The Evolution of Novel Combination Immunotherapies – Intralesional Treatments and New Targets for Treatment
Location:SSO HUB: Immuno-Oncology Zone
Teresa Kim
Kim, Tommy
University of Massachusetts Medical School
P66: Medicaid Expansion Increases Early Lung Cancer Diagnosis in Urban Blacks
Location:SSO HUB: Rare/Metastatic Cancers Zone
Tommy Kim
Kim, Uriel
CWRU School of Medicine
98: Disparities in Receipt of Complex GI Cancer Surgery at a Small Geographic Scale
Location:Ballroom A
Uriel Kim
Kim, Yesol
Washington University in St. Louis
22: The Long non-coding RNA RAMS11 Promotes Chemotherapy Resistance in-vivo in Metastatic Colorectal Cancer.
Location:Ballroom C
Yesol Kim
Kim, Young
Regeneron
23: Single-cell RNA Sequencing Reveals Distinct Populations of Tumor Associated Macrophages in Colorectal Metastasis.
Location:Ballroom C
Young Kim
Kindler, Hedy
Department of Medicine, Section of Hematology/Oncology, University of Chicago Medical Center
P53: Therapeutic Implications of Germline Testing in Peritoneal Mesothelioma
Location:SSO HUB: Rare/Metastatic Cancers Zone
Hedy Kindler
Kingham, T. Peter
Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center
27: The Prognostic Value of Pre- and Post-Neoadjuvant Chemotherapy Serum Carcinoembryonic Antigen Levels in Patients Having Resection of Colorectal Liver Metastases
Location:Ballroom C
T. Peter Kingham
35: Genetic Heterogeneity of Intrahepatic Cholangiocarcinoma: Implications for Outcome
Location:Veterans Memorial Auditorium
T. Peter Kingham
52: Adjuvant chemotherapy for resected intrahepatic cholangiocarcinoma confers no survival advantage.
Location:Ballroom A
T. Peter Kingham
King, Mary Caitlin
Mercy Medical Center
24: Sufficient Regional Lymph Node Examination for Staging High-Grade Appendix Cancer
Location:Ballroom C
Mary Caitlin King
King, Tari
Brigham and Womens Hospital, Dana Farber/Brigham Cancer Center
2: Racial disparities in locoregional recurrence in patients with stage I-III, hormone receptor positive breast cancer enrolled in the NSABP B-42 trial
Location:Veterans Memorial Auditorium
Tari King
4: Germline Genetic Mutations in a Prospective Multi-Center Cohort of 241 Phyllodes Tumors; Time to Expand Testing Criteria
Location:Veterans Memorial Auditorium
Tari King
Breast Great Debate: The Surgeon’s Role in Locoregional Management of Stage IV Breast Cancer
Location:Veterans Memorial Auditorium
Tari King
Kirane, Amanda
Stanford University
78: Detection of Circulating Tumor DNA Predicts Recurrence in Soft Tissue Sarcomas
Location:Ballroom A
Amanda Kirane
The Evolving Role of TIL Therapy in Melanoma
Location:SSO HUB Theater
Amanda Kirane
Kirkwood, John
UPMC Hillman Cancer Center
53: Surgical Outcomes of SWOG1801: Neoadjuvant/adjuvant versus adjuvant pembrolizumab for resectable stage III-IV melanoma
Location:Veterans Memorial Auditorium
John Kirkwood
63: Adjuvant therapy with nivolumab versus placebo in patients with resected stage IIB/C melanoma (CheckMate 76K)
Location:Veterans Memorial Auditorium
John Kirkwood
Kirstein, Laurie
Memorial Sloan Kettering Cancer Center
P73: How much does postoperative pain interfere with activities of daily living after breast surgery?
Location:SSO HUB: Rare/Metastatic Cancers Zone
Laurie Kirstein
Kitano, Mio
University of Texas Health San Antonio
P36: Campylobacter abundance is associated with an inflammatory immune signature in pancreatic cancer
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Mio Kitano
The Role of Minimal Residual Disease Detection in the Management of GI Cancers
Location:Ballroom A
Mio Kitano
Kleiner, David
NCI/NIH
P51: Hyperthermic intraperitoneal chemotherapy restores physiologic tumor stiffness & stimulates lymphocyte proliferation & recruitment
Location:SSO HUB: Rare/Metastatic Cancers Zone
David Kleiner
Klemen, Nicholas
National Cancer Institute
The Expanding Role of T cell Based Therapies in Cancer Care
Location:SSO HUB Theater
Nicholas Klemen
Klimberg, Suzanne
UTMB, MDACC
8: De-escalation of Post-Mastectomy Irradiation in Hormone Receptor-Positive Breast Cancer with One to Three Positive Nodes
Location:Veterans Memorial Auditorium
Suzanne Klimberg
Axillary Reverse Mapping (ARM)
Location:SSO HUB Theater
Suzanne Klimberg
Klingbeil, Kyle
UCLA Health
79: Dysregulation of Mitochondrial Dynamics via Dynamin-Related Protein 1 Implicated in Dedifferentiated Liposarcoma
Location:Ballroom A
Kyle Klingbeil
Kluger, Harriet
Yale University School of Medicine, Smilow Cancer Center, New Haven Hospital, NewHaven, CT, USA
64: Lifileucel TIL Cell Therapy in Patients With Advanced Melanoma After Progression on Immune Checkpoint Inhibitors (ICI) and Targeted Therapy: Tumor Tissue Procurement Data from the C-144-01 Study
Location:Veterans Memorial Auditorium
Harriet Kluger
Knauer, Michael
Tumor and Breast Center Eastern Switzerland, St. Gallen, Switzerland
12: Impact of imaging-guided localization on performance of tailored axillary surgery in patients with clinically node-positive breast cancer: Prospective study within TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)
Location:Veterans Memorial Auditorium
Michael Knauer
Knotts, Chelsea
Allegheny Health Network
69: Peritoneal fluid cytokine analysis reveals targets for regional immunotherapy in carcinomatosis
Location:Ballroom B
Chelsea Knotts
P55: Defining Values and Quality of Life of Cancer Survivors following Cytoreductive Surgery and HIPEC: An International Study
Location:SSO HUB: Rare/Metastatic Cancers Zone
Chelsea Knotts
Kobayashi, Kenya
Department of Otolaryngology, Head and Neck Surgery, The University of Tokyo.
P24: Genome doubling shapes the evolution and prognosis of advanced head and neck cancer
Location:SSO HUB: Breast & Endocrine Zone
Kenya Kobayashi
Koempel, Andrew
The Ohio State University Wexner Medical Center, The James Cancer Hospital and Solove Research Institute
67: Molecular mechanism of colorectal peritoneal metastasis: an interesting TWIST
Location:Ballroom B
Andrew Koempel
Koerber, Nicolas
Medical College of Wisconsin
87: Identifying Optimal Surgical Timing Relative to SARS-CoV-2 Infection Using COVID-19 Severity in Cancer Patients
Location:Ballroom B
Nicolas Koerber
Kollár, Attila
Department of Medical Oncology, Inselspital University Hospital Bern, Freiburgstrasse, Switzerland
77: Current Patterns of Care and Outcomes for Dermatofibrosarcoma Protuberans: An International Multi-institutional Collaborative
Location:Ballroom A
Attila Kollár
Kong, Amanda
Medical College of Wisconsin
SSO 2023 Pre-Meeting: SSO Fellows Institute II: Practical Aspects of Starting a Surgical Oncology Career (Separate Registration)
Location:Room 302
Amanda Kong
Kong, Seong-Ho
Seoul National University Hospital
92: Long-term outcomes of proximal gastrectomy for upper third advanced gastric and Siewert type II esophagogastric junction cancers in comparison with total gastrectomy: a propensity-score matched analysis
Location:Ballroom A
Seong-Ho Kong
Kooby, David A.
Emory University School of Medicine, Division of Surgical Oncology, Winship Cancer Institute
43: Optimal Duration of Chemotherapy in the Era of Neoadjuvant Therapy for Pancreatic Adenocarcinoma - Is There a Magic Number?
Location:Ballroom B
David A. Kooby
Korn, W. Michael
Caris Life Sciences
P7: Genomic characterization of breast cancer metastases reveals differences in rates of PIK3CA mutation across metastatic sites and worse survival in patients with concurrent CDH1 mutation treated with PI3K inhibitor
Location:SSO HUB: Breast & Endocrine Zone
W. Michael Korn
Koroukian, Siran
Dept of Population and Quantitative Health Sciences
98: Disparities in Receipt of Complex GI Cancer Surgery at a Small Geographic Scale
Location:Ballroom A
Siran Koroukian
Kosovec, Juliann
Duke University Medical Center
P60: Evolution in management of upfront treatment for desmoid tumors
Location:SSO HUB: Melanoma & Sarcoma Zone
Juliann Kosovec
Kothari, Anai
Medical College of Wisconsin, Department of Surgery, Division of Surgical Oncology
48: Machine Learning Derived Electronic Tumor Marker Mimics Prognostic Properties of CA19-9
Location:Ballroom A
Anai Kothari
87: Identifying Optimal Surgical Timing Relative to SARS-CoV-2 Infection Using COVID-19 Severity in Cancer Patients
Location:Ballroom B
Anai Kothari
Krainock, Michael
Natera, Inc.
Natera Industry Session: Know Cancer’s Next Move: How Personalized ctDNA testing Can Help Guide Perioperative Decision Making
Location:SSO HUB Theater
Michael Krainock
Krakorova, Dagmar
Department of Surgery, Masaryk Memorial Cancer Institute, Brno, Zluty kopec, Czech Republic
77: Current Patterns of Care and Outcomes for Dermatofibrosarcoma Protuberans: An International Multi-institutional Collaborative
Location:Ballroom A
Dagmar Krakorova
Kreger, Alexander
UCI Medical School
P49: Convolutional Neural Network to Predict Peritoneal Carcinomatosis Risk in Gastric Cancer
Location:SSO HUB: Rare/Metastatic Cancers Zone
Alexander Kreger
Krepler, Clemens
Merck & Co., Inc., Rahway, NJ, USA
54: Adjuvant Pembrolizumab in Stage II Melanoma: Outcomes by Tumor Location in the Phase 3 KEYNOTE-716 Study
Location:Veterans Memorial Auditorium
Clemens Krepler
krinshpun, Shifra
Natera
P33: Personalized Circulating Tumor DNA and Survival in Patients with Resectable Pancreatic Cancer
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Shifra krinshpun
Krishnamurthy, Savitri
MD Anderson Cancer Center
7: Multicenter clinical trial for omission of breast surgery in invasive cancer following neoadjuvant systemic therapy: Longitudinal patient reported outcomes and decisional comfort planned analyses
Location:Veterans Memorial Auditorium
Savitri Krishnamurthy
Krishnan, Kartik
OncoNano Medicine
65: Detection of Residual Peritoneal Metastases Following Cytoreductive Surgery Using Pegsitacianine, a pH Sensitive Imaging Agent: Topline Results from a Phase 2 Study
Location:Veterans Memorial Auditorium
Kartik Krishnan
Kubicky, Charlotte
Sutter Health
1: Impact of Breast Conservation Therapy on Local Recurrence in Patients with Multiple Ipsilateral Breast Cancer – Results from ACOSOG Z11102 (Alliance)
Location:Veterans Memorial Auditorium
Charlotte Kubicky
Kuchta, Kristine
North Shore University Health System
33: Validated Predictive Model for Prognosis and Treatment of Papillary Thyroid Carcinoma
Location:Ballroom A
Kristine Kuchta
Kucmanic, Matthew
University of Iowa
98: Disparities in Receipt of Complex GI Cancer Surgery at a Small Geographic Scale
Location:Ballroom A
Matthew Kucmanic
Kuerer, Henry
The University of Texas MD Anderson Cancer Center
5: Extremely Low Incidence of Local-Regional Recurrences Observed Among T1-2 N1 (1 or 2 Positive SLNs) Breast Cancer Patients Receiving Upfront Mastectomy Without Completion Axillary Node Dissection
Location:Veterans Memorial Auditorium
Henry Kuerer
7: Multicenter clinical trial for omission of breast surgery in invasive cancer following neoadjuvant systemic therapy: Longitudinal patient reported outcomes and decisional comfort planned analyses
Location:Veterans Memorial Auditorium
Henry Kuerer
Ku, Geoffrey
Memorial Sloan Kettering Cancer Center
P82: Short- and Long- Term Outcomes of Minimally Invasive vs Open Gastrectomy after Neoadjuvant Chemotherapy for Gastric cancer.
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Geoffrey Ku
Kunneth, Nick
University of Michigan
89: Variation in Postoperative Outcomes Across CMS Hospital Star Ratings for complex Cancer Surgery
Location:Ballroom B
Nick Kunneth
Kurtansky, Nicholas
Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center
P42: Clinical Benefit of Sentinel Lymph Node Biopsy Nomograms for Head and Neck Melanoma
Location:SSO HUB: Melanoma & Sarcoma Zone
Nicholas Kurtansky
Kurzeder, Christian
Breast Center, University Hospital Basel, Basel, Switzerland,University of Basel, Basel, Switzerland
12: Impact of imaging-guided localization on performance of tailored axillary surgery in patients with clinically node-positive breast cancer: Prospective study within TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)
Location:Veterans Memorial Auditorium
Christian Kurzeder
17: Axillary dissection to determine nodal burden to inform systemic therapy recommendations for clinically node-positive breast cancer: Pre-planned substudy of TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)
Location:Veterans Memorial Auditorium
Christian Kurzeder
Kwak, Hyunjee
University of Pennsylvania
75: T cell Inducible Costimulator (ICOS) blockade increases the efficacy of imatinib in Gastrointestinal Stromal Tumor (GIST)
Location:Ballroom A
Hyunjee Kwak
91: CD40 activation has direct tumor effects in gastrointestinal stromal tumor (GIST)
Location:Ballroom A
Hyunjee Kwak
Back to Top
